At the news
? NEUTRALIMPACT 3/10 3 filed Apr 10, 2026 at 16:05 ET
Scott Platshon, EVP and Chief Business Officer of Zymeworks, filed a Form 3 disclosing initial beneficial ownership and granting a power of attorney to Catherine Graham and Wilson Sonsini to file required Section 16 reports on his behalf. The filing reveals no current holdings but includes previously granted stock options and RSUs.
- Scott Platshon is EVP, Chief Business Officer of Zymeworks
- Filed Form 3 to report initial beneficial ownership
- Granted power of attorney to Catherine Graham and Wilson Sonsini attorneys to file Section 16 forms
- Currently holds no beneficially owned securities
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access